Literature DB >> 27550842

CRF receptor type 2 neurons in the posterior bed nucleus of the stria terminalis critically contribute to stress recovery.

M J A G Henckens1,2, Y Printz1, U Shamgar1, J Dine2, M Lebow1,2, Y Drori1,2, C Kuehne2, A Kolarz2, M Eder2, J M Deussing2, N J Justice3, O Yizhar1, A Chen1,2.   

Abstract

The bed nucleus of the stria terminalis (BNST) is critical in mediating states of anxiety, and its dysfunction has been linked to stress-related mental disease. Although the anxiety-related role of distinct subregions of the anterior BNST was recently reported, little is known about the contribution of the posterior BNST (pBNST) to the behavioral and neuroendocrine responses to stress. Previously, we observed abnormal expression of corticotropin-releasing factor receptor type 2 (CRFR2) to be associated with post-traumatic stress disorder (PTSD)-like symptoms. Here, we found that CRFR2-expressing neurons within the pBNST send dense inhibitory projections to other stress-related brain regions (for example, the locus coeruleus, medial amygdala and paraventricular nucleus), implicating a prominent role of these neurons in orchestrating the neuroendocrine, autonomic and behavioral response to stressful situations. Local CRFR2 activation by urocortin 3 depolarized the cells, increased the neuronal input resistance and increased firing of action potentials, indicating an enhanced excitability. Furthermore, we showed that CRFR2-expressing neurons within the pBNST are critically involved in the modulation of the behavioral and neuroendocrine response to stress. Optogenetic activation of CRFR2 neurons in the pBNST decreased anxiety, attenuated the neuroendocrine stress response, ameliorated stress-induced anxiety and impaired the fear memory for the stressful event. Moreover, activation following trauma exposure reduced the susceptibility for PTSD-like symptoms. Optogenetic inhibition of pBNST CRFR2 neurons yielded opposite effects. These data indicate the relevance of pBNST activity for adaptive stress recovery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27550842     DOI: 10.1038/mp.2016.133

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  36 in total

1.  Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression.

Authors:  Chien Li; Joan Vaughan; Paul E Sawchenko; Wylie W Vale
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Fighting in the home cage: Agonistic encounters and effects on neurobiological markers within the social decision-making network of house mice (Mus musculus).

Authors:  Gian D Greenberg; Chris L Howerton; Brian C Trainor
Journal:  Neurosci Lett       Date:  2014-03-03       Impact factor: 3.046

3.  Chronic cocaine administration switches corticotropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum.

Authors:  Jie Liu; Baojian Yu; Luis Orozco-Cabal; Dimitri E Grigoriadis; Jean Rivier; Wylie W Vale; Patricia Shinnick-Gallagher; Joel P Gallagher
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

Review 4.  Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.

Authors:  James P Herman; Michelle M Ostrander; Nancy K Mueller; Helmer Figueiredo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-11-04       Impact factor: 5.067

5.  Control of stress-induced persistent anxiety by an extra-amygdala septohypothalamic circuit.

Authors:  Todd E Anthony; Nick Dee; Amy Bernard; Walter Lerchner; Nathaniel Heintz; David J Anderson
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

6.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.

Authors:  K Van Pett; V Viau; J C Bittencourt; R K Chan; H Y Li; C Arias; G S Prins; M Perrin; W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

Review 7.  Stress-induced sensitization: the hypothalamic-pituitary-adrenal axis and beyond.

Authors:  Xavier Belda; Silvia Fuentes; Nuria Daviu; Roser Nadal; Antonio Armario
Journal:  Stress       Date:  2015-08-17       Impact factor: 3.493

8.  Central stress-integrative circuits: forebrain glutamatergic and GABAergic projections to the dorsomedial hypothalamus, medial preoptic area, and bed nucleus of the stria terminalis.

Authors:  Brent Myers; C Mark Dolgas; John Kasckow; William E Cullinan; James P Herman
Journal:  Brain Struct Funct       Date:  2013-05-10       Impact factor: 3.270

9.  Distinct extended amygdala circuits for divergent motivational states.

Authors:  Joshua H Jennings; Dennis R Sparta; Alice M Stamatakis; Randall L Ung; Kristen E Pleil; Thomas L Kash; Garret D Stuber
Journal:  Nature       Date:  2013-03-20       Impact factor: 49.962

Review 10.  Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders.

Authors:  M A Lebow; A Chen
Journal:  Mol Psychiatry       Date:  2016-02-16       Impact factor: 13.437

View more
  21 in total

1.  CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.

Authors:  Florence P Varodayan; Diego Correia; Dean Kirson; Sophia Khom; Christopher S Oleata; George Luu; Paul Schweitzer; Marisa Roberto
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

2.  Bed nuclei of the stria terminalis modulate memory consolidation via glucocorticoid-dependent and -independent circuits.

Authors:  Ryan T Lingg; Shane B Johnson; Eric B Emmons; Rachel M Anderson; Sara A Romig-Martin; Nandakumar S Narayanan; James L McGaugh; Ryan T LaLumiere; Jason J Radley
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

3.  Hypothalamic CRFR1 is essential for HPA axis regulation following chronic stress.

Authors:  Assaf Ramot; Zhiying Jiang; Jin-Bin Tian; Tali Nahum; Yael Kuperman; Nicholas Justice; Alon Chen
Journal:  Nat Neurosci       Date:  2017-01-30       Impact factor: 24.884

4.  Crh receptor priming in the bed nucleus of the stria terminalis (BNST) induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety.

Authors:  Nina C Donner; Sofia M Davies; Stephanie D Fitz; Drake M Kienzle; Anantha Shekhar; Christopher A Lowry
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-08-12       Impact factor: 5.067

5.  Targeting Corticotropin-Releasing Factor Projections from the Oval Nucleus of the Bed Nucleus of the Stria Terminalis Using Cell-Type Specific Neuronal Tracing Studies in Mouse and Rat Brain.

Authors:  J Dabrowska; D Martinon; M Moaddab; D G Rainnie
Journal:  J Neuroendocrinol       Date:  2016-12       Impact factor: 3.627

Review 6.  Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes: sex differences in regulation of stress responsivity.

Authors:  Mario G Oyola; Robert J Handa
Journal:  Stress       Date:  2017-08-31       Impact factor: 3.493

7.  Recovery of stress-impaired social behavior by an antagonist of the CRF binding protein, CRF6-33, in the bed nucleus of the stria terminalis of male rats.

Authors:  Mailton Vasconcelos; Dirson J Stein; Lucas Albrechet-Souza; Klaus A Miczek; Rosa Maria M de Almeida
Journal:  Behav Brain Res       Date:  2018-01-09       Impact factor: 3.332

Review 8.  Role of corticotropin-releasing factor in alcohol and nicotine addiction.

Authors:  Sierra Simpson; Kokila Shankar; Adam Kimbrough; Olivier George
Journal:  Brain Res       Date:  2020-04-21       Impact factor: 3.252

9.  Npas4a expression in the teleost forebrain is associated with stress coping style differences in fear learning.

Authors:  Matthew R Baker; Ryan Y Wong
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

10.  Corticotropin-releasing factor induces functional and structural synaptic remodelling in acute stress.

Authors:  Dorien Vandael; Keimpe Wierda; Katlijn Vints; Pieter Baatsen; Lies De Groef; Lieve Moons; Vasily Rybakin; Natalia V Gounko
Journal:  Transl Psychiatry       Date:  2021-07-07       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.